Tumour necrosis factor alpha gene (TNF-alpha)-376 polymorphism in Hungarian patients with primary progressive multiple sclerosis

Tumour necrosis factor alpha (TNF-alpha) is associated with clinical activity in relapsing-remitting multiple sclerosis (RRMS) and the development of progressive disease. Our aim was to investigate the TNF-alpha -376 polymorphism in primary progressive MS (PPMS) patients. Polymerase chain reaction a...

Teljes leírás

Elmentve itt :
Bibliográfiai részletek
Szerzők: Losonczi Erika
Bencsik Krisztina
Fricska-Nagy Zsanett
Honti Viktor
Szalczer Estilla
Rajda Cecília
Illés Zsolt László
Mátyás Klotild
Rózsa Csilla
Csépány Tünde
Füvesi Judit
Vécsei László
Dokumentumtípus: Cikk
Megjelent: 2009
Sorozat:JOURNAL OF NEUROIMMUNOLOGY 208 No. 1-2
doi:10.1016/j.jneuroim.2009.01.004

mtmt:1230928
Online Access:http://publicatio.bibl.u-szeged.hu/9950
LEADER 01852nab a2200337 i 4500
001 publ9950
005 20200128115320.0
008 161116s2009 hu o 0|| zxx d
022 |a 0165-5728 
024 7 |a 10.1016/j.jneuroim.2009.01.004  |2 doi 
024 7 |a 1230928  |2 mtmt 
040 |a SZTE Publicatio Repozitórium  |b hun 
041 |a zxx 
100 1 |a Losonczi Erika 
245 1 0 |a Tumour necrosis factor alpha gene (TNF-alpha)-376 polymorphism in Hungarian patients with primary progressive multiple sclerosis  |h [elektronikus dokumentum] /  |c  Losonczi Erika 
260 |c 2009 
300 |a 115-118 
490 0 |a JOURNAL OF NEUROIMMUNOLOGY  |v 208 No. 1-2 
520 3 |a Tumour necrosis factor alpha (TNF-alpha) is associated with clinical activity in relapsing-remitting multiple sclerosis (RRMS) and the development of progressive disease. Our aim was to investigate the TNF-alpha -376 polymorphism in primary progressive MS (PPMS) patients. Polymerase chain reaction and restriction fragment length polymorphism were carried out on 45 PPMS patients, 45 age and sex-matched RRMS patients and 45 healthy controls (HC). The GG genotype and the guanine allele (G) were detected significantly more often in the PPMS group as compared with the HC group (p=0.027; p=0.032). The G allele may be one of the factors responsible for progression in PPMS. 
700 0 1 |a Bencsik Krisztina  |e aut 
700 0 2 |a Fricska-Nagy Zsanett  |e aut 
700 0 2 |a Honti Viktor  |e aut 
700 0 2 |a Szalczer Estilla  |e aut 
700 0 2 |a Rajda Cecília  |e aut 
700 0 2 |a Illés Zsolt László  |e aut 
700 0 2 |a Mátyás Klotild  |e aut 
700 0 2 |a Rózsa Csilla  |e aut 
700 0 2 |a Csépány Tünde  |e aut 
700 0 2 |a Füvesi Judit  |e aut 
700 0 2 |a Vécsei László  |e aut 
856 4 0 |u http://publicatio.bibl.u-szeged.hu/9950/1/Losonczi_E._Tumour_necrosis_u.pdf  |z Dokumentum-elérés